Showing results (31-40 of 156) with videos related to

Sort By:
Pageof 16
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 20, 2022
[Comparative Safety Study of Original and Generic Docetaxel without Alcohol in the Treatment of Breast Cancer]Marie Hara, Tomoaki Eto, Hideki Ijichi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 27, 2016
[Antitumor Molecular Mechanism of Trifluridine and Tipiracil Hydrochloride (TAS-102: TFTD)]Hiroyuki Kitao, Kazuaki Matsuoka, Makoto Iimori, et al.
Anticancer Research|March 2, 2018
Impact of Visceral Metastasis on Efficacy of Fulvestrant in Patients with Hormone Receptor-positive Recurrent Breast CancerYumiko Koi, Chinami Koga, Sayuri Akiyoshi, et al.
Clinical Breast Cancer|December 25, 2017
Clinical Significance of the Wild Type p53-Induced Phosphatase 1 Expression in Invasive Breast CancerYuka Inoue, Nami Yamashita, Hiroyuki Kitao, et al.
Anticancer Research|September 6, 2017
The Local Recurrence of Breast Cancer with Squamous Metaplasia and Obvious Histological HeterogeneityNami Yamashita, Eriko Tokunaga, Hidetaka Yamamoto, et al.
Anticancer Research|April 5, 2017
A Locally Advanced Breast Cancer that Achieved pCR with Pertuzumab, Trastuzumab and Docetaxel: Case ReportYuka Inoue, Nami Yamashita, Eriko Tokunaga, et al.
Oncology Reports|March 10, 2006
Phase I study of S-1 and biweekly docetaxel combination chemotherapy for advanced and recurrent gastric cancerIkuo Takahashi, Yasunori Emi, Yoshihiro Kakeji, et al.
Plos One|December 16, 2016
Expression of APOBEC3B mRNA in Primary Breast Cancer of Japanese WomenEriko Tokunaga, Nami Yamashita, Kimihiro Tanaka, et al.
Breast Cancer (Tokyo, Japan)|October 9, 2009
Low incidence of methylation of the promoter region of the FANCF gene in Japanese primary breast cancerEriko Tokunaga, Satoko Okada, Hiroyuki Kitao, et al.
Pageof 16